<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
51079-067-20
</NDCCode>
<PackageDescription>
100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-067-20) > 1 TABLET in 1 BLISTER PACK (51079-067-01)
</PackageDescription>
<NDC11Code>
51079-0067-20
</NDC11Code>
<ProductNDC>
51079-067
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Diphenoxylate Hydrochloride And Atropine Sulfate
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Diphenoxylate Hydrochloride And Atropine Sulfate
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20130514
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA085762
</ApplicationNumber>
<LabelerName>
Mylan Institutional Inc.
</LabelerName>
<SubstanceName>
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
.025; 2.5
</StrengthNumber>
<StrengthUnit>
mg/1; mg/1
</StrengthUnit>
<Pharm_Classes>
Antidiarrheal [EPC],Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
</Pharm_Classes>
<DEASchedule>
CV
</DEASchedule>
<Status>
Deprecated
</Status>
<LastUpdate>
2015-07-31
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>